Healthcare and pharma
Launching a new drug in England
The prompt
A drug maker plans to launch a new drug in England at GBP 28,000 per course. Trials show it adds 0.5 QALYs per patient compared with the current treatment. About 8,000 patients a year are eligible, and about half would get it once approved. The exhibit summarizes the costs. Will it be approved at this price, and what should the company do?
Interviewer-led: the interviewer shows the cost table and asks for the cost per QALY.
Before you reveal anything, plan your own structure and first move on paper. Then reveal one part at a time and compare.